Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

97
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
97
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

64
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

35
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
35
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

54
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
54
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

51
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
51
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

42
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Retrospective patient-specific intravascular brachytherapy dosimetry using optical coherence tomography imaging.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Early versus delayed evolocumab treatment and complex coronary artery revascularization.

European journal of preventive cardiology·2026
Same author

Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.

Circulation·2026
Same author

Cardiovascular Regulatory Science: Accelerating the Path from Bench to Bedside.

American heart journal·2026
Same author

Early Versus Late Initiation of Evolocumab and Arterial Aneurysm Events: An Analysis of FOURIER and FOURIER-OLE.

Circulation·2026
Same author

Olezarsen for Hypertriglyceridemia and Pancreatitis Risk. Reply.

The New England journal of medicine·2026

Video Experimental Relacionado

Updated: Sep 28, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K

Síndromes coronarios agudos

Brian A Bergmark1, Njambi Mathenge2, Piera A Merlini3

  • 1TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Lancet (London, England)
|April 3, 2022
PubMed
Resumen
Este resumen es generado por máquina.

El diagnóstico y el tratamiento de los síndromes coronarios agudos (SAA) han avanzado, pero la enfermedad cardíaca isquémica sigue siendo una de las principales causas de muerte. Los ensayos de troponina de alta sensibilidad ayudan a descartar rápidamente el infarto de miocardio, siendo crucial la doble terapia antiplaquetaria y la prevención secundaria.

Más Videos Relacionados

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.1K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.8K

Videos de Experimentos Relacionados

Last Updated: Sep 28, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K
Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.1K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.8K

Área de la Ciencia:

  • Cardiología
  • Enfermedades cardiovasculares
  • Diagnóstico médico

Sus antecedentes:

  • Las enfermedades cardiovasculares son la principal causa mundial de muerte, principalmente debido a la enfermedad isquémica del corazón.
  • Los síndromes coronarios agudos (SCA) representan una porción significativa de la mortalidad cardiovascular.
  • A pesar del progreso, la evolución de la evidencia requiere una orientación clínica actualizada.

Objetivo del estudio:

  • Proporcionar una visión general clínicamente relevante de los síndromes coronarios agudos (SAC).
  • Resumir los avances científicos clave en la patobiología, el diagnóstico y el manejo de la EAC.
  • Para abordar el impacto de la pandemia de COVID-19 en la atención de ACS.

Principales métodos:

  • Revisión de la literatura científica y las directrices clínicas actuales.
  • Análisis de los avances en el diagnóstico, incluidos los ensayos de troponina de alta sensibilidad.
  • Evaluación de las estrategias terapéuticas, incluida la terapia antiplaquetaria dual y la prevención secundaria.

Principales resultados:

  • Los ensayos de troponina de alta sensibilidad facilitan los algoritmos de eliminación rápida para el infarto de miocardio no elevado del segmento ST (IEMSN).
  • Se recomienda una doble terapia antiplaquetaria durante 12 meses después del ACS.
  • La prevención secundaria intensiva, incluida la terapia para reducir los lípidos, es crítica.

Conclusiones:

  • La evolución continua de la evidencia científica tiene un impacto en el diagnóstico y el manejo de la EAC.
  • La adaptación de las estrategias de atención es esencial, especialmente a la luz de los eventos de salud globales como la pandemia de COVID-19.
  • Una comprensión completa de la patobiología y el manejo de la EAC es vital para reducir la mortalidad.